Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.24.1.1.u2
Condensed Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current Assets:    
Cash and cash equivalents $ 11,241 $ 4,928
Prepaid expenses and other current assets 734 450
Total current assets 11,975 5,378
Total Assets 11,975 5,378
Current Liabilities:    
Accounts payable and accrued expenses 19,159 15,485
Accounts payable and accrued expenses - related party 2,941 2,815
Common stock warrant liabilities 125 125
Total current liabilities 22,225 18,425
Total Liabilities 22,225 18,425
Commitments and Contingencies (note 5)
Stockholders' Equity (Deficit)    
Common stock issuable, 1,492,915 shares as of March 31, 2024 and December 31, 2023 3,419 3,419
Additional paid-in capital 311,605 297,864
Accumulated deficit (325,278) (314,333)
Total Stockholders' Equity (Deficit) (10,250) (13,047)
Total Liabilities and Stockholders' Equity (Deficit) 11,975 5,378
Common No Class    
Stockholders' Equity (Deficit)    
Common Stock Value $ 4 $ 3